TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Child domain of parenting stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MCQ results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OPE results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of central line colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: OHIP-14 (Oral Health Impact Profile)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: serologically detected gastric atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: pepsinogen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ocular discomfort relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in tear film quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of recommended questions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of correct details
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of ever drinking alcohol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of drinks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Past-month drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average percentage of measurements at the target ACT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACT in 300–350 s
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diminished post-acne erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Nasal polyp score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in smell sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sinus occupancy reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total score for social support
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Receptivity to RN SCM phone call
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fetal presentation at delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health and well-being related outcomes
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Scores on the CSBST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of cardiovascular outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: risk of kidney outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: yearly loss of eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Development of steatorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: postoperative bed rest time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Postoperative complications rates
Endpoint domain: Adverse events/effects
Primary endpoint: intracranial bleeding incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Posterior vein wall injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Obesity defined by BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: perceived cognitive function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: health perception status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Target Aneurysm Rupture (TAR)
Endpoint domain: Mortality/survival
Primary endpoint: Post-treatment residual aneurysm filling (Raymond III)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Post-treatment aneurysmal hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Early restart of daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Blood transfusion prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Quality of urine samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) for leg and back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insurance costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: atherogenic index of plasma value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: serum non-HDL-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients who are compliant
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of patients who complete follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 24 h urinary Mg excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PES and WES scores at 6 months after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual concerns
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HSV-2 acquisition
Endpoint domain: Adverse events/effects
Primary endpoint: Seroprotective titers in vaccinated women
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion in vaccinated women
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroprotective titers in infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity/specificity of the score system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the flow-chart integration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Risk of self-harm events
Endpoint domain: Adverse events/effects
Primary endpoint: proportion of compression on target area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of 30-s CST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean fracture strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total effective rate of YXR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total score of TCM syndromes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vascularization and disease activity correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Daily step count reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting LBF (Leg Blood Flow)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Resting LVC (Leg Vascular Conductance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ankle proprioception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NPRS measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: community functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: subjective quality of life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of breast cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of breast self-examination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Body dissatisfaction related to overweight
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Body dissatisfaction due to underweight
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Alcohol use in the previous year
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: time to first recurrence of syncope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: premonitory symptoms triggered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to TRB deflation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Minor rebleeding requiring TRB reinflation
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of sensor results within ±20%/20 mg/dL of YSI reference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of results within 15 mg/dL of YSI reference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of POC-CCA test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Specificity of POC-CCA test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Accuracy of POC-CCA test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Need to improve information measures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: occupational performance and function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Subjective happiness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Net Health Benefit score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incremental drug costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ClinTrialsESSDAI responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TS rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative fulfilment of expectation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: frequency of self-reported falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Understanding of cigarette smoking risks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Correct selection of smoking-related health conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rate of entropion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Duration of surgical time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Metal ion concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported outcomes (PRO)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean arterial PO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in time to complete TMT A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in time to complete TMT B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CPAP therapy requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related quality of life (Sleep Apnea Quality of Life Index)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: less tiredness
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: cognitive complaints
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: limb muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quadriceps femoris muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean creatinine level change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Confidence about how illness beliefs affected sexuality and intimacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall quality of the relationship
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Functional fitness performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of receiving reperfusion therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Probability of receiving multidisciplinary care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LGA rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SGA rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal complications
Endpoint domain: Adverse events/effects
Primary endpoint: Degree of treatment responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in skin parameters (color, melanin, hemoglobin, texture)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient and observer overall opinion score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Satisfaction scales rating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain during hospital stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tg < 0.2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sTg < 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck ultrasounds read as normal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative urethral and bladder pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative subjective urinary symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pads per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phonetics score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Access site complications rate
Endpoint domain: Adverse events/effects
Primary endpoint: 30-day perioperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Mean number of readmissions for AECOPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma symptom control (ACT score)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Daily OCS dose reduction
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Glucose control variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of participants with HbA1c <7.0%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of participants with HbA1c ≤6.5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absolute Eosinophil Count (AEC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Knowledge and perception of knowledge regarding professional ethics
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Response rate to health-related survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Donor site healing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: IC risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Additional/corrective procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Procedural difficulty
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Peak force to achieve 50% glottic opening view
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Impulse force to achieve 50% glottic opening view
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median force to achieve >80% glottic opening view
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: time to recover
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pSOFA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance to break the suction seal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum distraction force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak negative pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HLA-G +3142 C>G genotype frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICAM-1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: reduction of AHR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: satisfactory near vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life for near vision activities
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: BARC type 3-5 bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Perception of health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: anterior knee pain scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gait parameters during ambulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiomics score (RS) for predicting microvascular invasion (MVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: platelet inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol cue-elicited neural activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in GIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in red complex bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Average performance loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in RVSP (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PCCs' comfort discussing breast cancer screening options
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCCs' satisfaction with the CDS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Opiate-free patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first bone metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: time to first on‐study fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: time to first on‐study skeletal‐related event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lactate concentrations post-exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive airway pressure adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in oral morphine equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade ? 3 treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: number of clinic visits for vaccination
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: screening completion at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fixation construct failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average survival force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of mean scores SNOT22
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total self-harm
Endpoint domain: Adverse events/effects
Primary endpoint: Complete defect filling (MOCART score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pain and morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to oral fluid tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Any-grade adverse events
Endpoint domain: Adverse events/effects